Sign in
4

Changes in Ownership

Cardiff Oncology, Inc. Filed Acc 0000899243-19-000506

Chief Scientific Officer gave up 3,035 shares (to pay taxes)

  • Chief Scientific Officer acquired 7,500 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Erlander Mark · Chief Scientific Officer

Table I: Non-derivative

2 lines
Date Transaction Shares Owned after D/I
2019-01-01 Exercise or conversion : show line 1 in the form +7,500 21,180 D
2019-01-01 Shares withheld for taxes : show line 2 in the form −3,035 18,145 D

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2019-01-01 Exercise or conversion : show line 3 in the form Restricted Stock Units −7,500 34,688 D
Loading xslF345X03/doc4.xml…